These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7351458)

  • 1. Bartter's syndrome in a 74-year-old woman: response to anti-inflammatory agents.
    Gordon M; Pollard A
    J Am Geriatr Soc; 1980 Feb; 28(2):93-5. PubMed ID: 7351458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of amiloride on the renin-aldosterone system in primary hyperaldosteronism and Bartter's syndrome.
    Griffing GT; Aurecchia SA; Sindler BH; Melby JC
    J Clin Pharmacol; 1982; 22(11-12):505-12. PubMed ID: 6761369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone and other mineralocorticoids in Bartter's syndrome.
    Saruta T; Fujimaki M; Senba S; Saito I; Konishi K
    J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronization by indomethacin of the circadian rhythm of blood renin and aldosterone in a case of Bartter's syndrome].
    Cugini P; Lucia P; Murano G; Letizia C; Panichi G; Adone G; Vetere AM; Magnanelli S
    Minerva Urol Nefrol; 1985; 37(1):23-7. PubMed ID: 3901335
    [No Abstract]   [Full Text] [Related]  

  • 5. Captopril treatment in Bartter's syndrome.
    Scherling B; Verder H; Nielsen MD; Christensen P; Giese J
    Scand J Urol Nephrol; 1990; 24(2):123-5. PubMed ID: 2192445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value and limitations of indomethacin in the treatment of Bartter's syndrome].
    Dequiedt P; Lefebvre J; Raviart B; Vanhille P; Lepoutre E; Lelièvre G; Tacquet A
    J Urol Nephrol (Paris); 1977 Sep; 83(9):688-93. PubMed ID: 926230
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bartter's syndrome. Failure of aspirin and success of indomethacin].
    Jáuregui WO; Di Fonzo P; Marchissio ML; Roehr E; Hauger-Klevene JH
    Medicina (B Aires); 1979; 39(4):447-56. PubMed ID: 397398
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bartter's syndrome: Recurrence in the course of a treatment inhibiting prostaglandin synthesis].
    Favre L; Glasson P; Flory ED; Dray F; Vallotton MB
    Schweiz Med Wochenschr; 1979 Feb; 109(5):142-7. PubMed ID: 441720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandins and aspirin therapy in Bartter's syndrome.
    Norby L; Flamenbaum W; Lentz R; Ramwell P
    Lancet; 1976 Sep; 2(7986):604-6. PubMed ID: 61344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indomethacin for Bartter's syndrome.
    Zancan L; Zacchello F; Mantero F
    Lancet; 1976 Dec; 2(7999):1354. PubMed ID: 63823
    [No Abstract]   [Full Text] [Related]  

  • 11. Maternal Bartter's syndrome in pregnancy treated by amiloride.
    Deruelle P; Dufour P; Magnenant E; Courouble N; Puech F
    Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115(1):106-7. PubMed ID: 15223177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymptomatic Bartter's syndrome.
    Barbour GL; Day JO
    South Med J; 1978 Nov; 71(11):1341-4, 1349. PubMed ID: 715482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bartter's syndrome: the long term effects of indomethacin on growth (author's transl)].
    Floret D; David M; Roux A; Hage GN; Teyssier G
    Nouv Presse Med; 1979 Jan; 8(1):17-21. PubMed ID: 122007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses to antiotensin II antagonist before and after treatment with indomethacin in Bartter's syndrome.
    Sasaki H; Okumura M; Asano T; Arakawa K; Kawasaki T
    Br Med J; 1977 Oct; 2(6093):995-6. PubMed ID: 922403
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of Bartter's syndrome with indomethacin.
    Garin EH; Fennell RS; Iravani A; Richard GA
    Am J Dis Child; 1980 Mar; 134(3):258-61. PubMed ID: 6767392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism.
    Griffing GT; Melby JC
    Clin Exp Hypertens A; 1983; 5(6):779-801. PubMed ID: 6309436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of long-term treatment with spironolactone on sodium pump abnormalities in the red blood cells of patients with Bartter's syndrome.
    Horký K; Schreiber V; Dvoráková J
    Exp Clin Endocrinol; 1984 Jul; 84(1):105-11. PubMed ID: 6090182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypokalemia and prostaglandin overproduction in Bartter's syndrome.
    Senba S; Konishi K; Saruta T; Ozawa Y; Kato E; Amagasaki Y; Nakata I
    Nephron; 1984; 37(4):257-63. PubMed ID: 6379486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of indomethacin on the vascular abnormalities of Bartter's syndrome.
    Richards CJ; Mark AL; Van Orden DE; Kaloyanides GJ
    Circulation; 1978 Sep; 58(3 Pt 1):544-9. PubMed ID: 679446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total body potassium in Bartter's syndrome before and during treatment with enalapril.
    van de Stolpe A; Verhoef GE; Hené RJ; Koomans HA; van der Vijver JC
    Nephron; 1987; 45(2):122-5. PubMed ID: 3031521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.